Phase 1 trial uses enhanced T cells to treat neuroblastoma
A phase 1 clinical trial at Baylor College of Medicine, which has received support from a pediatric cancer nonprofit organization, will use an immunotherapy approach to treating kids with neuroblastoma.
Source: Baylor College of Medicine News - Category: Universities & Medical Training Source Type: news
More News: Baylor College of Medicine | Cancer | Cancer & Oncology | Children | Clinical Trials | Neuroblastoma | Neurology | Pediatrics | Universities & Medical Training